Angiotensin II receptor and HMG-CoA reductase — Drug Target

All drugs that target Angiotensin II receptor and HMG-CoA reductase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Angiotensin II receptor antagonist and statin

Phase 3 pipeline (1)

• valsartan + simvastatin · Novartis · Angiotensin II receptor antagonist and statin · Cardiovascular
  Valsartan is an angiotensin II receptor antagonist that blocks the effects of angiotensin II, a potent vasoconstrictor, thereby lowering blood pressure. Simvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis, thereby lowering cholesterol levels.